HF
ADMA icon

HRT Financial’s ADMA Biologics ADMA Stock Holding History

HRT Financial’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,195,051
Closed -$10.8M – 4078
2026
Q1 		$10.8M Buy
+1,195,051
New +$18.9M 0.03% 595
2025
Q4 		– Sell
-36,764
Closed -$538K – 3106
2025
Q3 		$538K Buy
+36,764
New +$630K ﹤0.01% 1852
2025
Q2 		– Sell
-75,785
Closed -$1.5M – 2513
2025
Q1 		$1.5M Buy
+75,785
New +$1.31M 0.01% 937
2024
Q2 		– Sell
-98,656
Closed -$651K – 2138
2024
Q1 		$651K Sell
98,656
-133,355
-57% -$729K ﹤0.01% 1113
2023
Q4 		$1.05M Sell
232,011
-17,495
-7% -$64.7K 0.01% 961
2023
Q3 		$893K Buy
249,506
+50,872
+26% +$196K 0.01% 1049
2023
Q2 		$732K Buy
+198,634
New +$736K 0.01% 1141
2023
Q1 		– Sell
-621,348
Closed -$2.41M – 2421
2022
Q4 		$2.41M Buy
+621,348
New +$1.92M 0.03% 506
2021
Q4 		– Sell
-118,099
Closed -$133K – 3093
2021
Q3 		$133K Buy
118,099
+40,158
+52% +$56.3K ﹤0.01% 2820
2021
Q2 		$124K Buy
77,941
+12,177
+19% +$21.4K ﹤0.01% 2538
2021
Q1 		$115K Buy
+65,764
New +$151K ﹤0.01% 2439
2020
Q3 		– Sell
-11,478
Closed -$33K – 1840
2020
Q2 		$33K Buy
+11,478
New +$33K ﹤0.01% 1351

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

HRT Financial's ADMA Position: Q2 2026 in Review

HRT Financial sold out of ADMA Biologics (ADMA) in Q2 2026, closing a stake of 1,195,051 shares — an estimated $10.8M sold.

HRT Financial first reported a position in ADMA in Q2 2020 and held it in 12 quarters. The position peaked at $10.8M in Q1 2026. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • HRT Financial reported no remaining ADMA Biologics position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 1,195,051 ADMA Biologics shares in Q2 2026, an estimated $10.8M.
  • HRT Financial first reported a position in ADMA Biologics in Q2 2020 and held it in 12 quarters.
  • HRT Financial's ADMA Biologics position peaked at $10.8M in Q1 2026.
  • 322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.